Inside this Issue ISSUE 1 | VOLUME 3
»
» » »
How has the introduction of Janus kinase (JAK) inhibitors into the treatment toolbox for patients with RA changed the way in which disease modifying anti-rheumatic drugs (DMARDs) are classified? How do JAK inhibitors compare to biologic DMARDs in terms of overall efficacy and safety? How can rheumatology nurses learn to be better communicators with their patients?
Earn CE Credits with Rheumatology Nurse Practice!
Why is it important for nurses and nurse practitioners to participate in accredited educational activities?
All issues of Rheumatology Nurse Practice will be CE certified in 2017 for the first time. To earn credits, please go to rnsnurse.org/rnpce, where you will be asked to register before accessing an activity post‑test and evaluation. You can then print out your CE certificate online.
RELEASE: APR 1, 2017 / EXPIRES: APR. 1, 2018
EDUCAT ION A L P L A N N I N G CO M M ITTE E :
Sheree C. Carter, PhD, RN, RN-BC
Iris Zink, MSN, NP, RN-BC
Elizabeth Kirchner, CNP, RN-BC
Jacqueline Fritz, RN, MSN, CNS, RN-BC
BOARD CERTIFIED IN RHEUMATOLOGY NURSING
BOARD CERTIFIED IN RHEUMATOLOGY NURSING
BOARD CERTIFIED IN RHEUMATOLOGY NURSING
BOARD CERTIFIED IN RHEUMATOLOGY NURSING
Assistant Professor The University of Alabama Capstone College of Nursing Tuscaloosa, Alabama
Nurse Practitioner Lansing Rheumatology Lansing, Michigan
Nurse Practitioner Cleveland Clinic Cleveland, Ohio
Critical Care and Rheumatology Specialist Medical Advancement Center Cypress, California
RNSnurse.org